FMP

FMP

Enter

ADPT - Adaptive Biotechnologies Corporation

Profile of Adaptive Biotechnologies Corporation(ADPT), Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platfo

photo-url-https://financialmodelingprep.com/image-stock/ADPT.png

Adaptive Biotechnologies Corporation

ADPT

NASDAQ

3.21 USD

0.32 (9.97%)

About

ceo

Mr. Chad M. Robins M.B.A.

sector

Healthcare

industry

Biotechnology

website

https://www.adaptivebiotech.com

exchange

NASDAQ

Description

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

CIK

0001478320

ISIN

US00650F1093

CUSIP

00650F109

Address

1165 Eastlake Avenue East

Phone

206 659 0067

Country

US

Employee

709

IPO Date

Jun 27, 2019

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep